Correction: Yang L, et al., “Targeting EBV-LMP1 DNAzyme enhances radiosensitivity of nasopharyngeal carcinoma cells by inhibiting telomerase activity”, Cancer Biol Ther 2014; 15:61–8

Documenti analoghi

• Targeting EBV-LMP1 DNAzyme enhances radiosensitivity of nasopharyngeal carcinoma cells by inhibiting telomerase activity
  di: Yang, Lifang, et al.
  Pubblicazione: (2014)
• EBV-LMP1 targeted DNAzyme enhances radiosensitivity by inhibiting tumor angiogenesis via the JNKs/HIF-1 pathway in nasopharyngeal carcinoma
  di: Yang, Lifang, et al.
  Pubblicazione: (2015)
• A Therapeutic Approach to Nasopharyngeal Carcinomas by DNAzymes Targeting EBV LMP-1 Gene
  di: Lun-Quan Sun, et al.
  Pubblicazione: (2010-09-01)
• A Therapeutic Approach to Nasopharyngeal Carcinomas by DNAzymes Targeting EBV LMP-1 Gene
  di: Yang, Lifang, et al.
  Pubblicazione: (2010)
• Delivery system for DNAzymes using arginine-modified hydroxyapatite nanoparticles for therapeutic application in a nasopharyngeal carcinoma model
  di: Chen, Yan, et al.
  Pubblicazione: (2013)